These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19032416)

  • 1. Obesity, insulin resistance, metabolic syndrome and graft function in children after renal transplantation--what does really matter?
    Litwin M; Socha P
    Pediatr Transplant; 2009 Aug; 13(5):516-20. PubMed ID: 19032416
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment.
    Wissing KM; Pipeleers L
    Transplant Rev (Orlando); 2014 Apr; 28(2):37-46. PubMed ID: 24507957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, metabolic syndrome, and lung function in US adolescents with and without asthma.
    Forno E; Han YY; Muzumdar RH; Celedón JC
    J Allergy Clin Immunol; 2015 Aug; 136(2):304-11.e8. PubMed ID: 25748066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome: a new view of some familiar transplant risks.
    Perkins JD
    Liver Transpl; 2006 Mar; 12(3):485-6. PubMed ID: 16498649
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of bariatric surgery in the treatment of severe obesity with proteinuria in a kidney transplant recipient.
    Montero ME; Garcia T; Delgado A; Mazuecos A
    Nephrology (Carlton); 2016 Apr; 21(4):342-3. PubMed ID: 27028417
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-transplant diabetes mellitus and renal function with tacrolimus: A decade of use, a decade of evidence. Foreword.
    Vanrenterghem Y
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi1-vi2. PubMed ID: 15575020
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation.
    Sui W; Zou H; Zou G; Yan Q; Chen H; Che W; Xie S
    Transpl Immunol; 2008 Nov; 20(1-2):95-8. PubMed ID: 18703143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.
    Shapiro R; Jordan ML; Scantlebury VP; Vivas C; Gritsch HA; Corry RJ; Egidi F; McCauley J; Ellis D; Gilboa N
    Clin Transpl; 1995; ():199-205. PubMed ID: 8794266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.
    Krämer BK; Klinger M; Vítko Š; Glyda M; Midtvedt K; Stefoni S; Citterio F; Pietruck F; Squifflet JP; Segoloni G; Krüger B; Sperschneider H; Banas B; Bäckman L; Weber M; Carmellini M; Perner F; Claesson K; Marcinkowski W; Ostrowski M; Senatorski G; Nordström J; Salmela K
    Transplantation; 2012 Sep; 94(5):492-8. PubMed ID: 22858806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comorbid states in paediatric and adolescent obesity. A simplified approach to their diagnosis: the metabolic syndrome].
    Moya M
    An Pediatr (Barc); 2011 May; 74(5):289-92. PubMed ID: 22369931
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic syndrome in kidney transplantation: management of risk factors.
    Hricik DE
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1781-5. PubMed ID: 21734094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the metabolic effects of calcineurin inhibitors in renal transplant recipients by urine metabolic profiling.
    Diémé B; Halimi JM; Emond P; Büchler M; Nadal-Desbarat L; Blasco H; Le Guellec C
    Transplantation; 2014 Jul; 98(2):195-201. PubMed ID: 24598938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems of metabolic syndrome diagnostics in children.
    Vitariusova E; Kostalova L; Pribilincova Z; Hlavata A; Kovacs L
    Endocr Regul; 2010 Jul; 44(3):115-20. PubMed ID: 20799854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
    Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A
    Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study.
    Dhuper S; Cohen HW; Daniel J; Gumidyala P; Agarwalla V; St Victor R; Dhuper S
    Cardiovasc Diabetol; 2007 Feb; 6():4. PubMed ID: 17300718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus.
    Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Valga EF; Barrientos A
    Transplant Proc; 2010 Oct; 42(8):2902-4. PubMed ID: 20970565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome.
    Brambilla P; Lissau I; Flodmark CE; Moreno LA; Widhalm K; Wabitsch M; Pietrobelli A
    Int J Obes (Lond); 2007 Apr; 31(4):591-600. PubMed ID: 17384660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolically healthy obesity: different prevalences using different criteria.
    Velho S; Paccaud F; Waeber G; Vollenweider P; Marques-Vidal P
    Eur J Clin Nutr; 2010 Oct; 64(10):1043-51. PubMed ID: 20628408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of fat tissue distribution on metabolic complications in children and adolescents with simple obesity].
    Firek-Pedras M; Małecka-Tendera E; Klimek K; Zachurzok-Buczyńska A
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):19-24. PubMed ID: 16704857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.